28 results on '"Friberg, Lena E."'
Search Results
2. Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data
3. Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data
4. Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model
5. Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response
6. Characterizing variability in warfarin dose requirements in children using modelling and simulation
7. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing
8. A simultaneous analysis of the time-course of leukocytes and neutrophils following docetaxel administration using a semi-mechanistic myelosuppression model
9. Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies
10. Comparison of the agonist-antagonist interaction model and the pool model for the effect of remoxipride on prolactin
11. Scaling the time-course of myelosuppression from rats to patients with a semi-physiological model
12. A Semi-Mechanistic Model of CP-690,550-Induced Reduction in Neutrophil Counts in Patients With Rheumatoid Arthritis
13. Model-Based Neutrophil-Guided Dose Adaptation in Chemotherapy: Evaluation of Predicted Outcome with Different Types and Amounts of Information
14. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS
15. Developmental Pharmacokinetics of Gentamicin in Preterm and Term Neonates: Population Modelling of a Prospective Study
16. Dose response of whole-grain biomarkers: alkylresorcinols in human plasma and their metabolites in urine in relation to intake1–3
17. Application of pharmacokinetic-pharmacodynamic modeling in management of QT abnormalities after citalopram overdose. Reply to A. Manini
18. Reply to Dr. Mégarbane et al. regarding “Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose”
19. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose
20. Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdoses
21. Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients
22. The Population Pharmacokinetics of Citalopram After Deliberate Self-Poisoning: A Bayesian Approach
23. Pharmacokinetic–pharmacodynamic modelling of the schedule-dependent effect of the anti-cancer agent CHS 828 in a rat hollow fibre model
24. Pharmacokinetic/Pharmacodynamic Modelling in Oncological Drug Development
25. Prediction of Irinotecan Pharmacokinetics by Use of Cytochrome P450 3A4 Phenotyping Probes
26. Mechanistic Models for Myelosuppression
27. Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs
28. Activated Charcoal Decreases the Risk of QT Prolongation After Citalopram Overdose
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.